The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoeck, M.
Right arrow Articles by Alkan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoeck, M.
Right arrow Articles by Alkan, S.

The Journal of Immunology, Vol 143, Issue 10 3258-3265, Copyright © 1989 by American Association of Immunologists


ARTICLES

Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2

M Stoeck, C Ruegg, S Miescher, S Carrel, D Cox, V Von Fliedner and S Alkan
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.

The effects of the newly isolated bovine milk growth factor (MGF) which shows N-terminal homology to transforming growth factor beta 2 were compared with the effects of porcine transforming growth factor beta 1 and beta 2 (pTGF-beta 1 and -beta 2) on human T lymphocyte activation. Freshly isolated human PBMC were stimulated with either PHA, anti-CD3 + phorbol-12,13-dibutyrate (PDBu), or with a combination of ionomycin + PDBu. MGF, pTGF-beta 1, and pTGF-beta 2 decreased mitogen-induced [3H]thymidine incorporation by 30 to 75% in a dose-dependent manner. The maximum degree of inhibition was obtained at 1 ng/ml (40 pM) and could not be increased by increasing the concentration of teh transforming growth factor 10-fold. Stimulation of fresh T cells with the recall Ag tetanus toxoid was also inhibited (85%) by MGF at pM concentrations as was the proliferation of a human T cell clone specific for purified protein derivative. The effects of MGF and pTGF- beta 1 on anti-CD3-mediated increase of intracellular Ca2+ (Cai2+) was investigated by using the Fura-2 method. Neither MGF nor pTGF-beta 1 inhibited this increase in Cai2+ induced by a mitogenic concentration of anti-CD3 antibody. In order to determine whether TGF-beta preferentially inhibited the CD4+ or CD8+ subpopulation of human T cells, a limiting dilution analysis system, which allows every T cell to proliferate, was used. pTGF-beta 1 at a concentration of 5 ng/ml decreased the frequency of proliferating T cell precursors of both the CD4+ and CD8+ subsets to a similar extent. Furthermore, MGF, pTGF-beta 1, and pTGF-beta 2 also decreased IL-2 mediated [3H]thymidine incorporation into human PBL Con A blasts and the IL-4-mediated [3H]thymidine incorporation of purified T lymphocytes costimulated with PDBu by 70%. In conclusion, bovine MGF exerts suppressive effects on human T cells stimulated with Ag, mitogens, or interleukins, and the degree of T cell suppression is similar (or identical) to those of pTGF- beta 1 or -beta 2.


This article has been cited by other articles:


Home page
J. Nutr.Home page
C. Davies, M. McConnell, L. Slobbe, N. Haggarty, and G. Buchan
Murine Antigen-Presenting Cells Are Multifunctional In Vitro Biosensors for Detecting the Immunoactive Potential of Bovine Milk Products
J. Nutr., November 1, 2005; 135(11): 2651 - 2656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-P. Kim, B.-G. Kim, J. Letterio, and W. J. Leonard
Smad-dependent Cooperative Regulation of Interleukin 2 Receptor {alpha} Chain Gene Expression by T Cell Receptor and Transforming Growth Factor-{beta}
J. Biol. Chem., October 7, 2005; 280(40): 34042 - 34047.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y. Nishikawa, R. Shibata, Y. Ozono, H. Ichinose, M. Miyazaki, T. Harada, and S. Kohno
Streptococcal M protein enhances TGF-{beta} production and increases surface IgA-positive B cells in vitro in IgA nephropathy
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 772 - 777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.